Skip to content
Home/Companies/Pharma/Focus Pharmaceuticals

Focus Pharmaceuticals

Pharma·UK·Exited 2014·Held 13yr
Entry
2001
Hold
13yr
Exit
2014

Who owns Focus Pharmaceuticals?

Focus Pharmaceuticals was owned by Mobeus Equity Partners through Mobeus VCTs (1998 vintage) from 2001 to 2014, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-01

Mobeus Equity Partners
Investor
Mobeus Equity Partners
Mobeus VCTs · 1998 · Evergreen

Key facts

HQUK
SectorPharma
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2014

More from Mobeus VCTs

Other portfolio companies in the same fund.

Redline Worldwide
Redline Worldwide
Exited 2019
CybersecurityUK· 2016
to
Access_IS
Access_IS
Exited 2020
IndustrialsUK· 2015
to
Jablite
Exited 2020
IndustrialsUK· 2015
to
Media Business Insight
Exited 2022
Business ServicesUK· 2015
to
Tharstern
Exited 2023
SoftwareUK· 2015
to
Tushingham Sails
Tushingham Sails
Exited 2021
ConsumerUK· 2015
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
AMW
AMW
Active
SHS Gesellschaft für BeteiligungsmanagementGermany· 2026
Basic Pharma
Active
SHS Gesellschaft für BeteiligungsmanagementNetherlands· 2026
Cinclus Pharma
Cinclus Pharma
Active
Claret Capital PartnersSweden· 2026
InfoRLife
Active
BC PartnersSwitzerland· 2026
IRAB
IRAB
Active
ARCHIMEDSpain· 2026
Track Focus Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Focus Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue